Dalteparin Thromboprophylaxis in Cancer Patients

Описание к видео Dalteparin Thromboprophylaxis in Cancer Patients

Dr. Alok Khorana of the Cleveland Clinic discusses his study on efficacy and safety of dalteparin thromboprophylaxis in cancer patients considered at high risk for venous thromboembolism. The use of risk scoring (Khorana score) to predict patients most at risk is discussed. The use of the Khorana risk scoring algorithm are reviewed. Finally, Dr. Khorana describes new, ongoing studies involving DOACs using risk scoring algorithms.
For more oncology news, education, and information, please visit http://www.oncology.tv/

Комментарии

Информация по комментариям в разработке

Похожие видео